Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
Reset 

John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Syneos Health, Inc

National Research Corporation Declares Special and Quarterly Dividend

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018

Varian Announces First Quarter Fiscal Year 2019 Earnings Release Date

PALO ALTO, Calif., Dec. 10, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will report results for the first quarter of fiscal year 2019 after market close on Wednesday, January 23, 2019. The news release will be followed by a teleconference available to all interested at 1:30... Read more ››

By: PR Newswire Association LLC. - 10 Dec 2018
Related companies:  Varian Medical Systems, Inc.

Global Markets for CT Scanners

NEW YORK, Dec. 10, 2018 /PRNewswire/ -- Report Scope

Read more ››
By: PR Newswire Association LLC. - 10 Dec 2018

Mirati Therapeutics Announces The Appointment Of Maya Martinez-Davis To The Board Of Directors

SAN DIEGO, Dec. 10, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the appointment of Maya Martinez-Davis to the Company's Board of Directors, effective immediately.

Read more ››
By: PR Newswire Association LLC. - 10 Dec 2018
Related companies:  Mirati Therapeutics, Inc.

Amgen And Lazarex Cancer Foundation Team Up To Allow More Diversity In Clinical Trials

THOUSAND OAKS, Calif. and SAN FRANCISCO, Dec. 10, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and the Lazarex Cancer Foundation, a non-profit organization focused on improving patient access to cancer clinical trials, today announced that they have teamed up to support more equitable access to clinical... Read more ››

By: PR Newswire Association LLC. - 10 Dec 2018
Related companies:  Amgen, Inc.

Rafael Holdings Reports First Quarter Fiscal Year 2019 Results

NEWARK, N.J., Dec. 10, 2018 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE American: RFL), reported revenue of $1.1 million and a loss per share of $0.04 for the first quarter of its 2019 fiscal year, the three months ended October 31, 2018.

Read more ››
By: PR Newswire Association LLC. - 10 Dec 2018

Medical Imaging Instrumentation: Global Markets and Technologies Through 2022

NEW YORK, Dec. 10, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 10 Dec 2018

Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data

SILVER SPRING, Md., Dec. 10, 2018 /PRNewswire/ -- Advancing medical device safety remains a top priority of the U.S. Food and Drug Administration. This means we are committed to communicating when new, relevant information becomes available about device safety risks, to ensure doctors and patients... Read more ››

By: PR Newswire Association LLC. - 10 Dec 2018
Related companies:  U.S. Food and Drug Administration

Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Basilea Pharmaceutica Ltd | Basilea Pharmaceutica Deutschland GmbH

Bio-on and Hera create Lux-on the new challenge to produce bioplastic from CO2.

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Bio-on S.p.A.

Mereo BioPharma to Present at The BMO Prescriptions for Success Healthcare Conference on 12 December 2018

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Medicure Inc. | Mereo BioPharma Group plc

German Clinic Orders Second Acarix CADScor®System to Further Boost Patient Capacity

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Acarix AB

Orphazyme expects to announce results of full data set for Niemann-Pick disease Type C (NPC) Phase II/III trial in Q1 2019

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Orphazyme A/S

OraSure Technologies Announces 2019 Annual Meeting Date

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  ORASURE TECHNOLOGIES, INC.

Achillion Interim Clinical Trial Data and Strategic Update Planned for Dec 17th, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Achillion Pharmaceuticals, Inc.

BeiGene to Present Clinical Data on Anti-PD-1 Antibody Tislelizumab at the European Society for Medical Oncology Immuno-Oncology Congress

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  BeiGene, Ltd.

Emblem launches new line of Oil Capsules

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Emblem Corp.

LHC Group and LifePoint Health expand partnership with two acquisitions in North Carolina and Virginia

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  LHC Group, Inc.

Active Biotech provides updated information about the company's financial position

Read more ››
By: Nasdaq / GlobenewsWire - 10 Dec 2018
Related companies:  Active Biotech AB
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
to the top ↑